Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction - PubMed (original) (raw)
Review
Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction
Philip Watson et al. Neuropsychol Rev. 2012 Sep.
Abstract
Systemic lupus erythematosus (SLE) is a multi-system autoimmune disorder characterized by the production of autoantibodies. Approximately 30-50 % of patients produce autoantibodies directed against N-Methyl-D-aspartic acid receptors (NMDARs). Once they have gained access to brain tissue, these autoantibodies bind to the NR2A subunit of the NMDARs and synergize with glutamate to cause excitatory, non-inflammatory cell death or alter neuron function. Both humans with SLE and animal models of SLE have shown structural and functional damage to the amygdala. The amygdala is a brain region important for processing the emotional relevance of stimuli in the environment. It also serves to modulate perception, attention, and memory to facilitate the processing and learning of relevant stimuli. Research has linked amygdala damage to deficits in emotional memory and emotional behavior. Individuals with SLE often exhibit emotional dysregulation, such as lability and depression; however, the behavioral impact of possible amygdala dysfunction has yet to be studied in this population. The purpose of this review is to 1) examine possible associations between SLE, anti-NMDAR antibodies, amygdala damage, and emotional processing deficits and 2) to identify the clinical, social, and treatment implications for individuals with SLE who suffer from deficits in emotional processing.
Similar articles
- Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
Harrison MJ, Ravdin LD, Lockshin MD. Harrison MJ, et al. Arthritis Rheum. 2006 Aug;54(8):2515-22. doi: 10.1002/art.22030. Arthritis Rheum. 2006. PMID: 16868972 - Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L, Bravo-Zehnder M, Calderón J, Flores P, Padilla O, Aguirre JM, Scoriels L, González A. Massardo L, et al. Lupus. 2015 May;24(6):558-68. doi: 10.1177/0961203314555538. Epub 2014 Oct 15. Lupus. 2015. PMID: 25318968 - Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T, Bleiberg J, Rosenstein D, Pao M, Patronas N, Steele S, Manzano M, van der Veen JW, Lipsky PE, Marenco S, Wesley R, Volpe B, Diamond B, Illei GG. Lapteva L, et al. Arthritis Rheum. 2006 Aug;54(8):2505-14. doi: 10.1002/art.22031. Arthritis Rheum. 2006. PMID: 16868971 - Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus.
Tay SH, Mak A. Tay SH, et al. Int J Mol Sci. 2015 May 6;16(5):10281-300. doi: 10.3390/ijms160510281. Int J Mol Sci. 2015. PMID: 25955648 Free PMC article. Review. - [An update on neuropsychiatric lupus with emphasis in cognitive dysfunction].
León T, Henríquez C, Calderón J, Massardo L. León T, et al. Rev Med Chil. 2012 Oct;140(10):1333-41. doi: 10.4067/S0034-98872012001000015. Rev Med Chil. 2012. PMID: 23559293 Review. Spanish.
Cited by
- Relevant Characteristics Analysis Using Natural Language Processing and Machine Learning Based on Phenotypes and T-Cell Subsets in Systemic Lupus Erythematosus Patients With Anxiety.
Gu XX, Jin Y, Fu T, Zhang XM, Li T, Yang Y, Li R, Zhou W, Guo JX, Zhao R, Li JJ, Dong C, Gu ZF. Gu XX, et al. Front Psychiatry. 2021 Dec 10;12:793505. doi: 10.3389/fpsyt.2021.793505. eCollection 2021. Front Psychiatry. 2021. PMID: 34955935 Free PMC article. - Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management.
Seet D, Allameen NA, Tay SH, Cho J, Mak A. Seet D, et al. Rheumatol Ther. 2021 Jun;8(2):651-679. doi: 10.1007/s40744-021-00312-0. Epub 2021 May 15. Rheumatol Ther. 2021. PMID: 33993432 Free PMC article. Review. - The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus.
Eudy AM, Clowse ME, Corneli A, McKenna K, Pisetsky DS, Maheswaranathan M, Burshell D, Doss J, Sun K, Sadun RE, Criscione-Schreiber LG, Rogers JL. Eudy AM, et al. Lupus. 2024 Mar;33(3):266-272. doi: 10.1177/09612033241228343. Epub 2024 Jan 18. Lupus. 2024. PMID: 38238905 Free PMC article. - Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development.
Pan Q, Chen X, Liao S, Chen X, Zhao C, Xu YZ, Liu HF. Pan Q, et al. PeerJ. 2019 Jun 25;7:e7179. doi: 10.7717/peerj.7179. eCollection 2019. PeerJ. 2019. PMID: 31275761 Free PMC article. - Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.
Jeltsch-David H, Muller S. Jeltsch-David H, et al. Nat Rev Neurol. 2014 Oct;10(10):579-96. doi: 10.1038/nrneurol.2014.148. Epub 2014 Sep 9. Nat Rev Neurol. 2014. PMID: 25201240 Review.
References
- Eur Neurol. 1999 Jul;42(1):41-8 - PubMed
- Behav Neurosci. 1994 Oct;108(5):1005-9 - PubMed
- Cogn Affect Behav Neurosci. 2002 Mar;2(1):52-63 - PubMed
- Biol Psychiatry. 2005 Feb 1;57(3):201-9 - PubMed
- Nat Med. 2001 Nov;7(11):1189-93 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical